2024-12-14 05:28:27
CICC looks forward to the insurance industry in 2025: investment opportunities may be easy first and then difficult. When CICC looks forward to the insurance industry in 2025, it said that it is expected that the stock market and policy expectations will still be the short-term main drivers of the stock price of the sector. Combined with the low profit base and the possible window period, the investment opportunities in the industry may be easy first and then difficult: the short-term stock market will rise sharply or reproduce the general market, and the investment logic will return to long-term contradictions such as interest rate trends after emotional calm.South Korean President Yin Xiyue: The opposition party is trying to destroy South Korea's growth engine.The restricted shares with a market value of 2.546 billion yuan were lifted today. Yongda, Sitaili and Dameng Data were among the top companies in terms of market value. On Thursday (December 12), the restricted shares of 8 companies were lifted, with a total lifting amount of 175 million shares. According to the latest closing price, the total lifting market value was 2.546 billion yuan. Judging from the amount of lifting the ban, the number of shares lifted by the two companies exceeded 10 million. Si Taili, Yongda and Ningxin New Materials were among the top, with 95,895,400 shares, 65,203,300 shares and 6,633,200 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by the two companies exceeded 100 million yuan. Yongda Co., Ltd., Sitaili and Dameng Data are among the top companies in terms of market value, with market values of 1.039 billion yuan, 992 million yuan and 349 million yuan respectively. Judging from the proportion of shares released from the ban to the total share capital, the proportion of the two companies released from the ban exceeded 10%. Yongda Co., Ltd., Sitaili Co., Ltd. and Ningxincai Co., Ltd. have the highest proportion of lifting the ban, accounting for 27.17%, 21.87% and 7.13% respectively.
Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.South Korean President Yin Xiyue made a speech to the people on the 12th, accusing the opposition party of framing "the crime of civil strife" and engaging in impeachment. (Xinhua News Agency)The vice chairman of Bosch's supervisory board said that as many as 10,000 jobs in Germany are at risk. Frank Sell, vice chairman of the supervisory board of Bosch, the world's top auto parts supplier, said on Wednesday that a series of layoffs announced by Bosch recently have put about 8,000-10,000 jobs in Germany at risk. Sell, who is also the chairman of the labor committee of Bosch's key business mobile solutions division, said that Bosch's overall plan has created an atmosphere that he called "absolutely intolerable" within the group. Bosch has about 135,000 employees in Germany.
South Korea's finance minister said that he would pay close attention to the financial market and respond to boost investor sentiment when necessary.Survey: Most Japanese companies expect Trump 2.0 to damage the business environment. According to a survey in Reuters, nearly three-quarters of Japanese companies expect Trump's second US presidency to have a negative impact on the business environment of Japanese companies. The reasons for concern include the planned tariff increase and trade tensions. The manager of a machinery manufacturer wrote in the survey: "It is difficult to predict his policies, which makes it difficult for our client company to make investment decisions"; Although 73% of the respondents said that Trump's second entry into the White House will not have a favorable impact on their business environment, the rest of the respondents expect a positive impact, including the expectation that domestic demand in the United States will expand through tax cuts, and energy and environmental policies may also be revised; When asked what measures they would take if Trump raised tariffs, two-thirds of the respondents said their business strategy was unlikely to change, 22% said they would cut costs, and 8% said they would work hard to expand their cultivation in markets outside the United States.Zhong Xuegao's subsidiary was forced to execute 16.62 million yuan. According to the legal litigation information, recently, Zhongmao (Shanghai) Food Technology Co., Ltd. added a piece of information about the person to be executed, with the execution target of 16.62 million yuan. The enforcement court is the Yangpu District People's Court in Shanghai. Zhongmao (Shanghai) Food Technology Co., Ltd. was established in June 2020. The legal representative is Wang Keqin, with a registered capital of RMB 10 million, and it is wholly owned by Zhong Xuegao Food (Shanghai) Co., Ltd. Tianyan risk information shows that the company has more than 20 pieces of information about executed persons, and the total amount of execution exceeds 31.62 million yuan. In addition, there are also a number of consumption restriction orders, untrustworthy executed persons (Lao Lai) and final case information.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14